LOTTE Fine Chemical is a South Korean specialty chemical manufacturer operating within the LOTTE Group conglomerate. Based on the financial reporting structure, the company operates through consolidated subsidiaries across chemical production and distribution. The company files as a 61-year-old entity (established approximately 1964), indicating a long operational history in Korea's chemical industry sector. Specific product segment details are not disclosed in the available balance sheet and income statement data.
[TRANSLATION NOTE: Detailed business segment descriptions would require translation of Korean business reports not included in this numerical filing data.]
LOTTE Fine Chemical is experiencing significant revenue and profitability headwinds. Revenue declined 5.5% year-over-year to KRW 1,671 billion in 2024 (from KRW 1,769 billion in 2023), continuing a steep downturn from KRW 2,464 billion in 2022. This represents a 32% revenue contraction over two years.
Operating profit collapsed 67.5% to KRW 50.4 billion in 2024 from KRW 154.8 billion in 2023, with operating margin compressing from 8.8% to just 3.0%. Net income fell 80% to KRW 36.4 billion (2024) from KRW 182 billion (2023), producing a razor-thin net margin of 2.2%.
The balance sheet remains conservatively managed with total debt (current + non-current liabilities) of KRW 345 billion against total assets of KRW 2,714 billion, yielding a low debt-to-asset ratio of 12.7%. Retained earnings stand at KRW 1,933 billion. Notably, non-current assets surged 25% to KRW 1,668 billion in 2024, suggesting significant capital investment during a profit downturn. Current assets decreased 22% to KRW 1,046 billion, potentially indicating working capital optimization or inventory destocking.
The available DART filing does not contain foreign ownership percentage or detailed shareholder registry data. As a LOTTE Group affiliate (evidenced by the company name), the entity is likely controlled by the LOTTE Group holding structure, but specific ownership percentages cannot be confirmed from this dataset.
[TRANSLATION NOTE: Ownership details would require separate disclosure documents not included in these consolidated financial statements.]
Margin Compression Under Revenue Pressure: The 67% operating profit decline against only 6% revenue decline indicates severe operating leverage working in reverse, suggesting high fixed costs, unfavorable product mix shifts, or raw material margin squeeze that management has been unable to mitigate.
Capital Intensity Timing: The company increased non-current assets by KRW 332 billion (25%) during 2024 while profits collapsed, raising questions about return timing on what appears to be major expansion or modernization capex deployed into a cyclical downturn.
LOTTE Fine Chemical presents as a conservatively financed but cyclically distressed chemical manufacturer with eroding margins and uncertain returns on recent heavy capital deployment, requiring clarity on end-market recovery timing and the strategic rationale behind expansion during downturn.
⚠️ This profile is AI-generated from DART filings. Quantitative data is reliable. Qualitative summaries should be verified against original Korean filings for investment decisions.